Menu
GWAS Study

Genetic associations of protein-coding variants in venous thromboembolism.

He XY, Wu BS, Yang L et al.

38561338 PubMed ID
GWAS Study Type
349038 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HX
He XY
WB
Wu BS
YL
Yang L
GY
Guo Y
DY
Deng YT
LZ
Li ZY
FC
Fei CJ
LW
Liu WS
GY
Ge YJ
KJ
Kang J
FJ
Feng J
CW
Cheng W
DQ
Dong Q
YJ
Yu JT
Chapter II

Abstract

Summary of the research findings

Previous genetic studies of venous thromboembolism (VTE) have been largely limited to common variants, leaving the genetic determinants relatively incomplete. We performed an exome-wide association study of VTE among 14,723 cases and 334,315 controls. Fourteen known and four novel genes (SRSF6, PHPT1, CGN, and MAP3K2) were identified through protein-coding variants, with broad replication in the FinnGen cohort. Most genes we discovered exhibited the potential to predict future VTE events in longitudinal analysis. Notably, we provide evidence for the additive contribution of rare coding variants to known genome-wide polygenic risk in shaping VTE risk. The identified genes were enriched in pathways affecting coagulation and platelet activation, along with liver-specific expression. The pleiotropic effects of these genes indicated the potential involvement of coagulation factors, blood cell traits, liver function, and immunometabolic processes in VTE pathogenesis. In conclusion, our study unveils the valuable contribution of protein-coding variants in VTE etiology and sheds new light on its risk stratification.

14,723 British ancestry cases, 334,315 British ancestry controls

Chapter III

Study Statistics

Key metrics and study information

349038
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.